Background: TLE1 immunohistochemistry (IHC) is widely used as a biomarker of synovial sarcoma. Recently, we described moderate to strong TLE1 expression in 57% of dermal spindle cell melanomas with an additional 33% with weak expression. The utility of TLE1 IHC in melanoma has not been well described. The aim of this study was to investigate TLE1 expression in melanoma.
Δευτέρα 6 Αυγούστου 2018
Utility of TLE1 immunohistochemistry in melanoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.